Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: results from a Spanish multicentre registry Salinas P, Galeote G, Martin-Reyes R, Perez-Vizcayno M, Hernández-Antolín R, Mainar V, Moreu J, de la Torre Hernandez J, Zueco J, Tello A, Jiménez-Valero S, Sanchez Recalde A, Calvo L, Plaza I, Alfonso F, Mariscal F, de Sa E, Macaya C, López-Sendón J-L, Moreno R April 20, 2011
Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents Moreno R, Jiménez-Valero S, Sanchez Recalde A, Galeote G, Calvo L, Martin-Reyes R, Sabate M, Plaza I, Macaya C, López-Sendón J-L March 21, 2011
A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial Moreno R, Garcia E, Teles R, Almeida M, Carvalho H, Sabate M, Martin-Reyes R, Rumoroso J-R, Galeote G, Goicolea F, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, Perez de Prado A, Martin-Yuste V, Jiménez-Valero S, Sanchez Recalde A, Calvo L, de Sa E, Macaya C, López-Sendón J-L May 25, 2010
Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis Sanchez Recalde A, Valero S, Moreno R, Barreales L, Lozano I, Galeote G, Reyes R, Calvo L, López-Sendón J-L May 25, 2010
Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents Rivero F, Moreno R, Barreales L, Galeote G, Sanchez Recalde A, Calvo L, Jiménez-Valero S, Villate A, Vanegas M, López-Sendón J-L May 13, 2008
JAA This week's JAA's: VR assisted conscious sedation during TAVI, Leipzig BASILICA experience... June 30, 2020